Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Cetuximab in combination therapy: From bench to clinic
David E. Gerber
,
Hak Choy
Hematology & Oncology
Internal Medicine
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Review article
›
peer-review
26
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cetuximab in combination therapy: From bench to clinic'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Apoptosis
9%
Biomarkers
10%
Cell Cycle Checkpoints
15%
Cell Proliferation
10%
Cetuximab
100%
Clinical Trials
10%
Colorectal Neoplasms
25%
Cytotoxins
17%
DNA Repair
14%
Drug Therapy
28%
ErbB Receptors
15%
Head and Neck Neoplasms
64%
Immunoglobulin G
12%
Irinotecan
18%
Ligands
11%
Lung Neoplasms
25%
Monoclonal Antibodies
11%
Neoplasms
10%
Oxaliplatin
18%
Radiotherapy
22%
Survival
17%
Therapeutics
13%